272 related articles for article (PubMed ID: 15520163)
1. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
[TBL] [Abstract][Full Text] [Related]
2. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
3. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
Lin HK; Hu YC; Lee DK; Chang C
Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
[TBL] [Abstract][Full Text] [Related]
4. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
5. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T; Okahara F; Kanaho Y
Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
[TBL] [Abstract][Full Text] [Related]
7. The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K
Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552
[TBL] [Abstract][Full Text] [Related]
8. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
9. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
McMenamin ME; Soung P; Perera S; Kaplan I; Loda M; Sellers WR
Cancer Res; 1999 Sep; 59(17):4291-6. PubMed ID: 10485474
[TBL] [Abstract][Full Text] [Related]
10. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
11. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
12. The role of PTEN in the progression and survival of prostate cancer.
Deocampo ND; Huang H; Tindall DJ
Minerva Endocrinol; 2003 Jun; 28(2):145-53. PubMed ID: 12717346
[TBL] [Abstract][Full Text] [Related]
13. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M
Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639
[TBL] [Abstract][Full Text] [Related]
15. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis.
Bandyopadhyay S; Pai SK; Watabe M; Gross SC; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Markwell SJ; Wang Y; Huggenvik J; Pauza ME; Iiizumi M; Watabe K
Oncogene; 2005 Aug; 24(34):5389-95. PubMed ID: 15897909
[TBL] [Abstract][Full Text] [Related]
16. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
17. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
18. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
19. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Piquemal D; Commes T; Watabe M; Gross SC; Wang Y; Ran S; Watabe K
Oncogene; 2004 Jul; 23(33):5675-81. PubMed ID: 15184886
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]